Odonate Therapeutics, Inc. Operating Expenses
Odonate Therapeutics, Inc. reported Operating Expenses of $14.02 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-11-10
- Odonate Therapeutics, Inc. operating expenses for the quarter ending 2021-09-30 was $14.02M, a 54.27% decline year-over-year.
- Odonate Therapeutics, Inc. operating expenses for the quarter ending 2021-06-30 was $22.05M, a 34.22% decline year-over-year.
- Odonate Therapeutics, Inc. operating expenses for the quarter ending 2021-03-31 was $33.82M, a 9.72% increase year-over-year.
- Odonate Therapeutics, Inc. operating expenses for the quarter ending 2020-12-31 was $32.43M, a 12.98% increase year-over-year.
- Odonate Therapeutics, Inc. operating expenses for fiscal 2020 was $127.43M, a 10.88% increase from fiscal 2019.
- Odonate Therapeutics, Inc. operating expenses for fiscal 2019 was $114.93M, a 26.63% increase from fiscal 2018.
- Odonate Therapeutics, Inc. operating expenses for fiscal 2018 was $90.76M, a 177.19% increase from fiscal 2017.
- Odonate Therapeutics, Inc. operating expenses for fiscal 2017 was $32.74M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-09-30 | $14.02M 10-Q · filed 2021-11-10 | $36.07M derived: sum of 2 quarters · filed 2021-11-10 | $69.89M 10-Q · filed 2021-11-10 | $102.32M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $22.05M 10-Q · filed 2021-07-27 | $55.87M 10-Q · filed 2021-07-27 | $88.31M derived: sum of 3 quarters · filed 2021-07-27 | $118.96M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $33.82M 10-Q · filed 2021-05-14 | $66.25M derived: sum of 2 quarters · filed 2021-05-14 | $96.90M derived: sum of 3 quarters · filed 2021-11-10 | $130.43M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $32.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $63.08M derived: sum of 2 quarters · filed 2021-11-10 | $96.61M derived: sum of 3 quarters · filed 2021-11-10 | $127.43M 10-K · filed 2021-02-23 |
| 2020-09-30 | $30.65M 10-Q · filed 2021-11-10 | $64.18M derived: sum of 2 quarters · filed 2021-11-10 | $95.00M 10-Q · filed 2021-11-10 | $123.71M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $33.53M 10-Q · filed 2021-07-27 | $64.35M 10-Q · filed 2021-07-27 | $93.06M derived: sum of 3 quarters · filed 2021-07-27 | $120.82M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $30.82M 10-Q · filed 2021-05-14 | $59.53M derived: sum of 2 quarters · filed 2021-05-14 | $87.29M derived: sum of 3 quarters · filed 2021-05-14 | $116.53M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $28.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $56.47M derived: sum of 2 quarters · filed 2021-02-23 | $85.71M derived: sum of 3 quarters · filed 2021-02-23 | $114.93M 10-K · filed 2021-02-23 |
| 2019-09-30 | $27.76M 10-Q · filed 2020-10-28 | $57.00M derived: sum of 2 quarters · filed 2020-10-28 | $86.22M 10-Q · filed 2020-10-28 | $115.70M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $29.24M 10-Q · filed 2020-07-30 | $58.46M 10-Q · filed 2020-07-30 | $87.94M derived: sum of 3 quarters · filed 2020-07-30 | $112.56M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $29.22M 10-Q · filed 2020-04-28 | $58.70M derived: sum of 2 quarters · filed 2020-04-28 | $83.33M derived: sum of 3 quarters · filed 2020-04-28 | $103.11M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | $29.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $54.10M derived: sum of 2 quarters · filed 2020-02-20 | $73.88M derived: sum of 3 quarters · filed 2020-02-20 | $90.76M 10-K · filed 2020-02-20 |
| 2018-09-30 | $24.63M 10-Q · filed 2019-11-06 | $44.41M derived: sum of 2 quarters · filed 2019-11-06 | $61.29M 10-Q · filed 2019-11-06 | $77.03M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $19.78M 10-Q · filed 2019-07-24 | $36.66M 10-Q · filed 2019-07-24 | $52.41M derived: sum of 3 quarters · filed 2019-07-24 | $62.78M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $16.88M 10-Q · filed 2019-04-25 | $32.63M derived: sum of 2 quarters · filed 2019-04-25 | $43.00M derived: sum of 3 quarters · filed 2019-04-25 | $46.90M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $15.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $26.12M derived: sum of 2 quarters · filed 2019-02-22 | $30.02M derived: sum of 3 quarters · filed 2019-02-22 | $32.74M 10-K · filed 2019-02-22 |
| 2017-09-30 | $10.37M 10-Q · filed 2018-10-23 | $14.27M derived: sum of 2 quarters · filed 2018-10-23 | $17.00M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | $3.90M 10-Q · filed 2018-07-30 | $6.63M 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | $2.73M 10-Q · filed 2018-05-03 |